10. July 2018
Future Market Insights (FMI) delivers key insights on the global biologic excipients market in its upcoming report titled “Biologic Excipients Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018 – 2028”. In terms of revenue, the global biologic excipients market is projected to register a CAGR of 3.6% over the forecast period owing to various factors, regarding which FMI offers detailed insights and forecasts in this report. Global Biologic Excipients Market:...
31. May 2017
EXCiPACT asbl is delighted to announce that the Ashland Speciality Ingredients site in Doel, Belgium has recently been awarded an EXCiPACT GMP Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies. The Certificate demonstrates that the Ashland Speciality Ingredients (ASI) site in Doel, Belgium, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers the production of...
31. March 2017
The majority of today’s new chemi- cal entities are poorly water-soluble. One widely used means of overcom- ing that problem is to develop solid dispersions by mixing at the molecular level the drug candidate into a polymer matrix [1]. Spray drying and hot-melt extrusion (HME) are the most common technologies used to manufacture these amorphous solid dispersions. With spray drying, an organic solvent dissolves the API and polymer, followed by rapid removal of the solvent. With HME, an...
25. October 2016
Ashland has opened a pharmaceutical excipients plant in Nanjing, China in a bid to capture growing local demand for modern formulation technologies. http://www.in-pharmatechnologist.com/Ingredients/Ashland-opens-Nanjing-excipient-plant-citing-growing-local-demand-in-light-of-new-quality-regulations
11. August 2015
Information & Registration http://curtiscoulter.com/event/2nd-annual-oral-drug-formulation-innovations-summit/